UNH vs BMY
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Bristol-Myers Squibb Company, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | BMY |
|---|---|---|
| Price | $418.09 | $61.48 |
| Market cap | $375.28B | $125.59B |
| P/E ratio | 26.9 | 13.5 |
| ROE | 15.77% | 46.60% |
| Profit margin | 3.53% | 18.87% |
| Revenue growth | -0.40% | 5.70% |
| Dividend yield | 2.22% | 4.10% |
| Beta | 0.61 | 0.18 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs BMY in plain English
- UNH is the bigger company — about 3.0× the market cap of BMY.
- BMY is cheaper on earnings (P/E 13.5 vs 26.9).
- BMY earns a higher return on equity (47% vs 16%).
- BMY is growing revenue faster (6% vs -0%).
- BMY has the higher dividend yield (4.10% vs 2.22%).
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
BMY return calculator
See what $1,000 in Bristol-Myers Squibb Company would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.